Pulse Biosciences, Inc.PLSENASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+150.2%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+150.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
15.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20252434.67-
20240.00-
20230.00-100.0%
2022155.45-44.4%
2021279.82-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-